Correlation Between Annexon and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Annexon and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Akari Therapeutics PLC, you can compare the effects of market volatilities on Annexon and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Akari Therapeutics.
Diversification Opportunities for Annexon and Akari Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Annexon and Akari is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Annexon i.e., Annexon and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Annexon and Akari Therapeutics
Given the investment horizon of 90 days Annexon is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Annexon is 1.54 times less risky than Akari Therapeutics. The stock trades about -0.41 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 121.00 in Akari Therapeutics PLC on November 2, 2024 and sell it today you would earn a total of 11.00 from holding Akari Therapeutics PLC or generate 9.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Annexon vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Annexon |
| Akari Therapeutics PLC |
Annexon and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annexon and Akari Therapeutics
The main advantage of trading using opposite Annexon and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Annexon vs. Immix Biopharma | Annexon vs. Cns Pharmaceuticals | Annexon vs. Hepion Pharmaceuticals | Annexon vs. Day One Biopharmaceuticals |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |